Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venostan for Postoperative Swelling in Ankle Fractures
NCT06872034Recruiting
- Sponsor
- Beijing Jishuitan Hospital
- Start
- Apr 2025
- Primary completion
- Jan 2026
- Modality
- Hydrogel Systems, Transdermal Patches
- Countries
- 1
01
Overview
Randomised, open-label trial of Horse chestnut seed extract in edema (2 arms), sponsored by Beijing Jishuitan Hospital. Primary endpoint: Change in ankle circumference at 6 days postoperatively compared to baseline. Started Apr 2025; status: recruiting.
02
Drugs
Horse chestnut seed extract
03
Conditions
edema
Beyond the preview
Go deeper on NCT06872034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06872034.